(Q82770029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Pediatric rheumatology: JIA, treatment and possible risk of malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Nicolino Ruperto

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Alberto Martini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

7 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Rheumatology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

6-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135880%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrrheum.2010.199

17 January 2020

exact match

0 references

cites work

Juvenile idiopathic arthritis: state of the art and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.199

Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.199

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.199

Malignancies in children who initially present with rheumatic complaints

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.199

Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.199

Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.199

Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.199